Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05255471
Title MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients. (MITO 35B)
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute, Naples
Indications

fallopian tube cancer

peritoneum cancer

ovarian cancer

Therapies

Carboplatin + Paclitaxel

Olaparib

Carboplatin + Pegylated liposomal-doxorubicin

Carboplatin + Gemcitabine

Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.